Natixis’s Outset Medical OM Stock Holding History

Natixis’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,044	Closed	-$247K	–	1162
2023 Q4	$247K	Sell	3,044 -724	-19%	-$58.9K	﹤0.01%	690
2023 Q3	$615K	Sell	3,768 -598	-14%	-$141K	﹤0.01%	575
2023 Q2	$1.43M	Sell	4,366 -25	-0.6%	-$7.63K	0.01%	481
2023 Q1	$1.21M	Sell	4,391 -4,652	-51%	-$1.71M	0.01%	490
2022 Q4	$3.5M	Buy	9,043 +6,179	+216%	+$1.74M	0.02%	440
2022 Q3	$702K	Sell	2,864 -127	-4%	-$34K	﹤0.01%	831
2022 Q2	$681K	Buy	+2,991	New	+$1.29M	﹤0.01%	894

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Natixis's OM Position: Q1 2024 in Review

Natixis sold out of Outset Medical (OM) in Q1 2024, closing a stake of 3,044 shares — an estimated $247K sold.

Natixis first reported a position in OM in Q2 2022 and held it in 7 quarters. The position peaked at $3.5M in Q4 2022. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

Natixis reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
Natixis sold 3,044 Outset Medical shares in Q1 2024, an estimated $247K.
Natixis first reported a position in Outset Medical in Q2 2022 and held it in 7 quarters.
Natixis's Outset Medical position peaked at $3.5M in Q4 2022.
114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.